<VariationArchive VariationID="864674" VariationName="NM_133433.4(NIPBL):c.8331del (p.Ala2777_Leu2778insTer)" VariationType="Deletion" Accession="VCV000864674" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="830858" VariationID="864674">
      <GeneList>
        <Gene Symbol="NIPBL" FullName="NIPBL cohesin loading factor" GeneID="25836" HGNC_ID="HGNC:28862" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="36876769" stop="37066413" display_start="36876769" display_stop="37066413" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="36876860" stop="37065920" display_start="36876860" display_stop="37065920" Strand="+" />
          </Location>
          <OMIM>608667</OMIM>
          <Haploinsufficiency last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NIPBL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NIPBL">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_133433.4(NIPBL):c.8331del (p.Ala2777_Leu2778insTer)</Name>
      <CanonicalSPDI>NC_000005.10:37064807:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="37064808" stop="37064808" display_start="37064808" display_stop="37064808" variantLength="1" positionVCF="37064807" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="37064910" stop="37064910" display_start="37064910" display_stop="37064910" variantLength="1" positionVCF="37064909" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.37064808del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.37064808del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.37064910del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.37064910del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_006987.2" sequenceAccession="NG_006987" sequenceVersion="2" change="g.192926del">
            <Expression>NG_006987.2:g.192926del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015384.5" sequenceAccession="NM_015384" sequenceVersion="5" change="c.*785del">
            <Expression>NM_015384.5:c.*785del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133433.4" sequenceAccession="NM_133433" sequenceVersion="4" change="c.8331del" MANESelect="true">
            <Expression>NM_133433.4:c.8331del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_597677.2" sequenceAccession="NP_597677" sequenceVersion="2" change="p.Ala2777_Leu2778insTer">
            <Expression>NP_597677.2:p.Ala2777_Leu2778insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1755224830" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_133433.4(NIPBL):c.8331del (p.Ala2777_Leu2778insTer) AND Cornelia de Lange syndrome 1" Accession="RCV001071919" Version="7">
        <ClassifiedConditionList TraitSetID="548">
          <ClassifiedCondition DB="MedGen" ID="C4551851">Cornelia de Lange syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20824775</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1016" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cornelia de Lange syndrome 1</ElementValue>
                <XRef ID="MONDO:0007387" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brachmann de Lange syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Typus degenerativus amstelodamensis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDLS</ElementValue>
                <XRef Type="MIM" ID="122470" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CDLS1</ElementValue>
                <XRef Type="MIM" ID="122470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C4551851" DB="MedGen" />
              <XRef ID="MONDO:0007387" DB="MONDO" />
              <XRef Type="MIM" ID="122470" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2402940" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6396215|MedGen:CN029798" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001237251" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20824775</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the NIPBL protein. Other variant(s) that disrupt this region (p.Arg2793*) have been observed in individuals with NIPBL-related conditions (PMID: 20824775). This suggests that this may be a clinically significant region of the protein. This variant has been observed to be de novo in an individual with Cornelia de Lange syndrome (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the NIPBL gene (p.Leu2778*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 27 amino acids of the NIPBL protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NIPBL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.37064910del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN029798" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2402940" TraitType="Disease" MappingType="XRef" MappingValue="CN029798" MappingRef="MedGen">
        <MedGen CUI="C4551851" Name="Cornelia de Lange syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

